LONA:NASDAQ
LeonaBio Inc
USDÂ 4,94
0,00%
(0,00) 1D
30 Okt., 15:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LONA...
Mkt. cap
46,54Â m
Avg. vol.
361,46Â k
Volume
22,00
52-wk high
USDÂ 14,21
52-wk low
USDÂ 2,21
EPS
-USDÂ 19,72
Beta
2,11
Shares outstanding
9,42Â m
No. of employees
19
Mkt. cap
46,54Â m
Avg. vol.
361,46Â k
Volume
22,00
52-wk high
USDÂ 14,21
52-wk low
USDÂ 2,21
EPS
-USDÂ 19,72
Beta
2,11
Shares outstanding
9,42Â m
No. of employees
19
News stories
From web sources and news partners
www.marketscreener.com
·
32 minute gelede
Stellantis Chooses Amperity to Personalize Experiences: NYSE Content Update
The Motley Fool
·
5 minute gelede
Here's How Warren Buffett's Berkshire Hathaway Stock Did in Every S&P 500 Down Year Since 2000
Morningstar
·
23 minute gelede
U.S. Index Futures Turn to Jobs Data and Treasury's Refunding After Friday's 3.46% Nasdaq-100 Drop
Seeking Alpha
·
56 minute gelede
SPYM: S&P 500 Monthly Dashboard For November (NYSEARCA:SPYM)
Profile
Athira Pharma is a late clinical stage American biopharmaceutical company developing small-molecule therapeutics targeting neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. The company's lead candidate, ATH-1017, is in human studies for Alzheimer's disease as of 2021.
The company was founded in 2011 and is headquartered in Seattle. Funding that supports the company is from both public and private investment groups including the Alzheimer's Drug Discovery Foundation, Dolby Family Ventures, the State of Washington's Life Sciences Discovery Fund, The W Fund, WRF Capital, and other private investors.
Leen Kawas served as the company's first President and CEO, but resigned in October 2021, after an independent special committee found she "altered images in scientific papers she authored." In 2025, the company paid a $4 million settlement in relation to allegations that the CEO falsified research to secure a federal grant. On October 21, 2021, Mark Litton, Ph.D., M.B.A. became chief executive officer. Wikipedia
About LeonaBio Inc
CEO-
Employees19
Founded2011
HeadquartersBothell, Washington, Verenigde State van Amerika
SectorPharmaceutical industry
Websiteleonabio.com